Results
20,939 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Alpern Paul LVP and General Counsel |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $77K 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Alpern Paul LVP and General Counsel | AIPArteris, Inc. Open-market sale · 10b5-1 plan | SELL | $77K 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 | |
Feierstein Matthew DavidPresident |
 EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $121K 10.0K sh |
| Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $102K 9,280 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Bachrodt AmySVP, Finance |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $8,830 200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Gummadi SuryaPresident - Americas |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOpen-market sale · 10b5-1 plan | SELL | $144K 1,728 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $139K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $159K 14.7K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $108K 10.0K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 6 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $8,388 720 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Saldanha CraigChief Product Officer |  YELPYELP INCOpen-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Vultaggio VincentPAO and PFO |  ZNTLZentalis Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $6,477 2,540 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $20K 1,700 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $30K 2,797 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 1 | Vultaggio VincentPAO and PFO | ZNTLZentalis Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $1,398 556 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 1 | Kozarich John WDirector |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $75K 381 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Sieffert Kristen NPresident |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $17K 750 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Barrett David MichaelDirector, Chief Executive Officer |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $44K 30.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $7,449 39 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,499 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $192 1 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,535 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 37 | Running Michael J.Regional President - AMER |  PLXSPLEXUS CORPOpen-market sale | SELL | $190K 926 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 33 | Dechairo BryanChief Operating Officer |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $165K 1,662 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 33 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $117K 1,166 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 30 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $49K 492 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 29 | Lee David EricVICE CHAIR, WINTRUST FINANCIAL |  WTFCWINTRUST FINANCIAL CORPOpen-market sale | SELL | $82K 558 sh | Feb 3, 2026 traded Jan 30, 2026 |
| 26 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $8,999 93 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 19 | Robinson Jill L.EVP, CFO & Treasurer |  BATRKAtlanta Braves Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $800K 20.0K sh | Feb 3, 2026 traded Feb 2, 2026 |
| 10 | Malcolm JanDirector |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $24K 50 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 10 | Smith Chad M.Pres & COO, Better Mortgage |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $84K 3,097 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 9 | Ohlgart ChristianeChief Financial Officer |  FTNTFortinet, Inc.Open-market sale · 10b5-1 plan | SELL | $41K 507 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 6 | Jedrzejek DavidSVP and General Counsel |  LEVILEVI STRAUSS & COOpen-market sale · 10b5-1 plan | SELL | $44K 2,248 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 4 | Badjate PramodPresident & GM, NFB |  NTGRNETGEAR, INC.Open-market sale · 10b5-1 plan | SELL | $63K 3,000 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 1 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $38K 1,462 sh | Feb 3, 2026 traded Jan 30, 2026 |
| 39 | Donovan James JosephChief Lending Officer/FSVP |  UNTYUNITY BANCORP INC /NJ/Open-market sale | SELL | $14K 265 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 35 | Krohne Susan EChief Legal Officer, Secretary |  MHOM/I HOMES, INC.Open-market sale | SELL | $671K 5,000 sh | Feb 2, 2026 traded Jan 30, 2026 |
| 22 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $154K 3,500 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 22 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 2,800 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 21 |  Thomas RagyDirector |  CXMSprinklr, Inc.Open-market sale | SELL | $6,693 1,054 sh | Feb 2, 2026 traded Jan 29, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $184 2 sh | Feb 2, 2026 traded Jan 29, 2026 |